Target intelligence / Profile preview

OC183B2 antigen (OC183B2)

Target: OC183B2
Molecular classification: Antigen

Overview

The OC183B2 antigen is associated with ovarian cancer and is used as a target for developing diagnostic and therapeutic tools. It is specifically expressed in certain ovarian cancer cell lines and tissues, making it a potential biomarker for ovarian cancer detection and treatment.

Other names: OC183B2

Mechanism of action

Targeting the antigen for diagnostic or therapeutic purposes

Biological functions

Immune responsecell recognition

Disease associations

Cancer (specifically ovarian cancer)

Biomarkers

OC183B2 expression in ovarian cancer tissues

Beyond the preview

Go deeper on OC183B2 antigen (OC183B2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OC183B2 antigen (OC183B2).

Explore the full profile